Stock 600557 JIANGSU KANION PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jiangsu Kanion Pharmaceutical Co.,Ltd.

Equities

600557

CNE000001CL7

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
18.36 CNY -2.08% Intraday chart for Jiangsu Kanion Pharmaceutical Co.,Ltd. -7.51% -10.53%
Apr. 25 Jiangsu Kanion Pharmaceutical Co.,Ltd. Equity Buyback Plan Extended till February 5, 2025. CI
Apr. 12 Jiangsu Kanion Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,739 6,030 7,055 10,961 11,999 10,463 - -
Enterprise Value (EV) 1 9,016 6,030 7,055 10,961 11,999 10,463 10,463 10,463
P/E ratio 17.1 x 23.1 x 21.9 x 25 x 22.1 x 16 x 13.5 x 11.3 x
Yield 0.54% - - - 1.8% 2.17% 2.33% 2.5%
Capitalization / Revenue 1.91 x 1.99 x 1.93 x 2.52 x 2.46 x 1.81 x 1.56 x 1.37 x
EV / Revenue 1.91 x 1.99 x 1.93 x 2.52 x 2.46 x 1.81 x 1.56 x 1.37 x
EV / EBITDA 11.7 x - 13 x 16.9 x 15.9 x 12.7 x 8.78 x 9.18 x
EV / FCF - - - - 16.1 x 45.1 x 11.6 x 11.3 x
FCF Yield - - - - 6.21% 2.22% 8.63% 8.84%
Price to Book 2.22 x - 1.64 x 2.31 x 2.31 x 1.8 x 1.64 x 1.47 x
Nbr of stocks (in thousands) 592,881 592,881 576,429 584,598 584,748 580,948 - -
Reference price 2 14.74 10.17 12.24 18.75 20.52 18.01 18.01 18.01
Announcement Date 4/9/20 4/9/21 3/3/22 2/20/23 3/10/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,566 3,032 3,649 4,351 4,868 5,786 6,694 7,660
EBITDA 1 746.3 - 542.1 648.3 754.5 822 1,192 1,140
EBIT 1 578.9 - 351 454.8 563.8 688.6 823.9 978.5
Operating Margin 12.68% - 9.62% 10.45% 11.58% 11.9% 12.31% 12.77%
Earnings before Tax (EBT) 1 575.4 - 328.3 445.7 551 674.4 811 966
Net income 1 507 - 320.5 434.5 536.7 659.1 778.6 932.4
Net margin 11.1% - 8.79% 9.99% 11.03% 11.39% 11.63% 12.17%
EPS 2 0.8600 0.4400 0.5600 0.7500 0.9300 1.123 1.331 1.595
Free Cash Flow 1 - - - - 745.6 232 903 925
FCF margin - - - - 15.32% 4.01% 13.49% 12.08%
FCF Conversion (EBITDA) - - - - 98.81% 28.22% 75.75% 81.15%
FCF Conversion (Net income) - - - - 138.91% 35.2% 115.97% 99.21%
Dividend per Share 2 0.0800 - - - 0.3700 0.3900 0.4200 0.4500
Announcement Date 4/9/20 4/9/21 3/3/22 2/20/23 3/10/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 - 942.9 1,372 1,359 1,357 1,065 1,550 1,712 1,520
EBITDA - - - - - - - - -
EBIT - - - - - - - - -
Operating Margin - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - -
Net income 134.3 - - - - - - - -
Net margin - - - - - - - - -
EPS 0.2300 - - - - - - - -
Dividend per Share - - - - - - - - -
Announcement Date 7/12/23 10/25/23 3/10/24 4/12/24 - - - - -
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 277 - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) 0.3708 x - - - - - - -
Free Cash Flow 1 - - - - 746 232 903 925
ROE (net income / shareholders' equity) 12.9% - 7.57% 9.61% 10.8% 11.4% 12.1% 13%
ROA (Net income/ Total Assets) - - - - - 8.23% 8.53% 9.27%
Assets 1 - - - - - 8,005 9,133 10,062
Book Value Per Share 2 6.640 - 7.470 8.130 8.880 10.00 11.00 12.30
Cash Flow per Share 2 1.560 - 1.590 1.700 1.780 1.350 2.060 1.600
Capex 1 449 - 142 189 295 325 650 311
Capex / Sales 9.83% - 3.9% 4.35% 6.07% 5.61% 9.71% 4.06%
Announcement Date 4/9/20 4/9/21 3/3/22 2/20/23 3/10/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Jiangsu Kanion Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
18.01 CNY
Average target price
25.17 CNY
Spread / Average Target
+39.77%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANGSU KANION PHARMACEUTICAL CO.,LTD. Stock Jiangsu Kanion Pharmaceutical Co.,Ltd.
-10.53% 1.47B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+39.75% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.28% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.63% 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.29% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.88% 282B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 244B
NOVARTIS AG Stock Novartis AG
+9.31% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-5.07% 205B
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600557 Stock
  4. Financials Jiangsu Kanion Pharmaceutical Co.,Ltd.